Question

Is stem cell therapy for Male Infertility FDA-approved?

No generic stem-cell or exosome product is FDA-approved to treat male infertility. A fertility-clinic licence, tissue-bank registration or research listing is not product approval for this use.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Male Infertility

Male infertility can result from impaired sperm production, obstruction, hormonal or genetic disorders, infection, medicines, systemic disease or unexplained factors. Cell research includes laboratory generation or support of germ cells, but this is not equivalent to clinically proven restoration of fertility. MSC, testicular-cell and exosome products have different risks and must not be grouped under one regenerative label.

Am I a candidate? → · Male Infertility: full overview → · Male Infertility cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information